---
title: "IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286817922.md"
description: "IDEXX Laboratories Inc. (IDXX) shares rose 3.21% to $545.79 on a mixed trading day, while the Dow Jones increased by 0.32% and the S&P 500 fell by 0.07%. Despite the gain, IDXX remains 29.12% below its 52-week high of $769.98. Competitors like Johnson & Johnson, Medtronic, and Boston Scientific also saw stock increases, with Boston Scientific leading at 6.15%. Trading volume for IDXX was 633,490, surpassing its 50-day average of 559,521."
datetime: "2026-05-18T20:51:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286817922.md)
  - [en](https://longbridge.com/en/news/286817922.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286817922.md)
---

# IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of IDEXX Laboratories Inc. (IDXX) advanced 3.21% to $545.79 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.32% to 49,686.12 and the S&P 500 Index falling 0.07% to 7,403.05.

IDEXX Laboratories Inc. closed 29.12% below its 52-week high of $769.98, which the company reached on November 26th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) rose 0.97% to $228.92, Medtronic PLC (MDT) rose 1.54% to $77.32, and Boston Scientific Corp. (BSX) rose 6.15% to $55.92.

Trading volume (633,490) eclipsed its 50-day average volume of 559,521.

Data source: Dow Jones Market Data, FactSet. Data compiled May 18, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-18-26 1651ET

### Related Stocks

- [IDXX.US](https://longbridge.com/en/quote/IDXX.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IDNA.US](https://longbridge.com/en/quote/IDNA.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IHF.US](https://longbridge.com/en/quote/IHF.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day | IDXX Stock News](https://longbridge.com/en/news/286464576.md)
- [Engaging In Insider Activity, Sam Samad At IDEXX Laboratories Exercises Options Worth $0](https://longbridge.com/en/news/286585689.md)
- [BUZZ-Boston Scientific shares rise on $2 bln accelerated buyback](https://longbridge.com/en/news/286801797.md)
- [Boston Scientific Targets Growing Aortic Stenosis Market With $1.5 Billion Deal](https://longbridge.com/en/news/286808399.md)
- [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)